Supplementary Legends from TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma
Authors:
- Hiroyuki NishiyamaHNHiroyuki Nishiyama
- Junji YoneseJYJunji Yonese
- Takashi KawaharaTKTakashi Kawahara
- Ryuji MatsumotoRMRyuji Matsumoto
- Hideaki MiyakeHMHideaki Miyake
- Nobuaki MatsubaraNMNobuaki Matsubara
- Hiroji UemuraHUHiroji Uemura
- Masatoshi EtoMEMasatoshi Eto
- Haruhito AzumaHAHaruhito Azuma
- Wataru ObaraWOWataru Obara
- Akito TeraiATAkito Terai
- Satoshi FukasawaSFSatoshi Fukasawa
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)